These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31930215)

  • 21. Analysis of drug resistance and mutation profiles in
    Zhang J; Ren Y; Pan L; Yi J; Guan T; Yang X; Zhang Z
    J Int Med Res; 2021 Jan; 49(1):300060520984932. PubMed ID: 33461383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.
    Devaux I; Manissero D; Fernandez de la Hoz K; Kremer K; van Soolingen D;
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.
    Mogashoa T; Melamu P; Derendinger B; Ley SD; Streicher EM; Iketleng T; Mupfumi L; Mokomane M; Kgwaadira B; Rankgoane-Pono G; Tsholofelo TT; Kasvosve I; Moyo S; Warren RM; Gaseitsiwe S
    Pathogens; 2019 Oct; 8(4):. PubMed ID: 31661825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
    Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
    Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
    Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
    PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of drug-resistant Mycobacterium tuberculosis in Hainan Island, China.
    Lin M; Zhong Y; Chen Z; Lin C; Pei H; Shu W; Pang Y
    Trop Med Int Health; 2019 Sep; 24(9):1098-1103. PubMed ID: 31278806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Levels of Extensively Drug-resistant Tuberculosis among Multidrug Resistant Tuberculosis Isolates and Their Relationship to Risk Factors: Surveillance in Tehran, Iran; 2006 to 2014.
    Tasbiti AH; Yari S; Ghanei M; Shokrgozar MA; Fateh A; Bahrmand A
    Osong Public Health Res Perspect; 2017 Apr; 8(2):116-123. PubMed ID: 28540155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates.
    Lombardi G; Dal Monte P; Denicolò A; Tadolini M; Martelli G; Bacchi Reggiani ML; Viale P; Landini MP
    BMC Public Health; 2014 Apr; 14():340. PubMed ID: 24721236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada.
    Alexander PE; De P
    Can J Infect Dis Med Microbiol; 2007 Sep; 18(5):289-91. PubMed ID: 18923728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.
    Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS
    Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
    PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demographic, laboratory and clinical characteristics of HIV-positive tuberculosis cases in Canada.
    Wang GJ; Phypers M; Ellis E
    J Infect Public Health; 2009; 2(3):112-9. PubMed ID: 20701870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
    Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
    BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.